Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 374,500 shares, a growth of 32.2% from the March 15th total of 283,300 shares. Based on an average daily trading volume, of 100,100 shares, the short-interest ratio is presently 3.7 days. Approximately 1.2% of the company's shares are sold short.

Vivani Medical Stock Up 0.5 %

Shares of Vivani Medical stock traded up $0.01 during trading hours on Thursday, hitting $1.04. The company's stock had a trading volume of 27,125 shares, compared to its average volume of 167,104. The business has a fifty day moving average of $1.08 and a 200 day moving average of $1.19. The company has a market capitalization of $61.31 million, a PE ratio of -2.30 and a beta of 2.76. Vivani Medical has a 1-year low of $0.91 and a 1-year high of $2.09.

Vivani Medical (NASDAQ:VANI - Get Free Report) last issued its quarterly earnings data on Monday, March 31st. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01). On average, sell-side analysts anticipate that Vivani Medical will post -0.41 earnings per share for the current fiscal year.

Insider Activity at Vivani Medical

In other Vivani Medical news, Director Gregg Williams purchased 44,400 shares of Vivani Medical stock in a transaction on Monday, April 7th. The shares were bought at an average price of $0.99 per share, with a total value of $43,956.00. Following the purchase, the director now directly owns 4,799,200 shares in the company, valued at $4,751,208. This trade represents a 0.93 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Over the last 90 days, insiders have bought 107,809 shares of company stock valued at $107,644. Company insiders own 44.30% of the company's stock.

Institutional Investors Weigh In On Vivani Medical

A number of hedge funds have recently bought and sold shares of VANI. Northern Trust Corp increased its position in shares of Vivani Medical by 19.1% in the 4th quarter. Northern Trust Corp now owns 71,915 shares of the company's stock worth $83,000 after purchasing an additional 11,540 shares during the last quarter. Geode Capital Management LLC raised its stake in Vivani Medical by 4.6% during the third quarter. Geode Capital Management LLC now owns 342,891 shares of the company's stock valued at $401,000 after buying an additional 15,008 shares in the last quarter. Wealthedge Investment Advisors LLC bought a new position in Vivani Medical during the 4th quarter worth approximately $43,000. Finally, Jane Street Group LLC bought a new stake in shares of Vivani Medical in the 4th quarter valued at approximately $66,000. Institutional investors and hedge funds own 6.78% of the company's stock.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a "buy" rating and set a $4.00 price objective on shares of Vivani Medical in a report on Wednesday, April 16th.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.